Combine dengue vaccines to optimize effectiveness
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trialThe Lancet, 2020
- Is Dengvaxia a useful vaccine for dengue endemic areas?BMJ, 2019
- Dengue vaccine: WHO position paper, September 2018 – RecommendationsVaccine, 2019
- DengueThe Lancet, 2019
- The immune response against flavivirusesNature Immunology, 2018
- Effect of Dengue Serostatus on Dengue Vaccine Safety and EfficacyNew England Journal of Medicine, 2018
- Original antigenic sin: A comprehensive reviewJournal of Autoimmunity, 2017
- A Critical Assessment of Vector Control for Dengue PreventionPLOS Neglected Tropical Diseases, 2015
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study YearPLOS Neglected Tropical Diseases, 2013
- Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in BangkokProceedings of the National Academy of Sciences, 2006